NCT00343122

Brief Summary

The purpose of the study is to evaluate agitated saline versus polygeline for detection of intrapulmonary vasodilatation in patients with cirrhosis.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2006

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

June 20, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 22, 2006

Completed
Last Updated

September 17, 2007

Status Verified

September 1, 2007

First QC Date

June 20, 2006

Last Update Submit

September 14, 2007

Conditions

LiverCirrhosis

Keywords

livercirrhosishepatopulmonary syndrome

Interventions

echocardiography for intrapulmonary vasodilatationPROCEDURE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \> 18 years
  • presence of liver cirrhosis
  • evaluation for liver transplantation or transjugular intrahepatic portosystemic shunt

You may not qualify if:

  • inadequate echocardiographic image quality
  • allergies to echocardiographic contrast agents
  • pulmonary valve stenosis
  • pulmonary embolism
  • relevant tricuspid regurgitation
  • cardiomyopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Intensive Care Unit 13H1, Dep. of Internal Medicine IV, Medical University of Vienna

Vienna, Vienna, A-1090, Austria

RECRUITING

Related Publications (1)

  • Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB; ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J. 2004 Nov;24(5):861-80. doi: 10.1183/09031936.04.00010904. No abstract available.

    PMID: 15516683BACKGROUND

MeSH Terms

Conditions

FibrosisHepatopulmonary Syndrome

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsLiver DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract Diseases

Study Officials

  • Peter Schenk, MD

    Intensive Care Unit 13h1, Dep. of Internal Medicine IV, Medical University of Vienna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Valentin Fuhrmann, MD

CONTACT

0043-1-40400valentin.fuhrmann@meduniwien.ac.at

Peter Schenk, MD

CONTACT

0043-1-40400

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 20, 2006

First Posted

June 22, 2006

Study Start

June 1, 2006

Last Updated

September 17, 2007

Record last verified: 2007-09

Locations

AU(1)